Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
        • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
      • Recently Published Guidelines
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
      • Brigham and Women's Hospital
      • Hartford Hospital
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Instituto do Coração-INCOR (São Paulo, Brasil)
      • Minneapolis City Hospital
      • Parkland Hospital: Dallas, Texas
      • Pennsylvania Hospital, Philadelphia
      • Pitié-Salpêtrière Hospital
      • Royal Infirmary of Edinburgh, Scotland
      • Tufts Medical Center
      • University of Michigan
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
      • Women's College Hospital, Toronto, Canada
      • Henry Ford Hospital, Detroit, Michigan
      • Instituto Nacional de Cardiología Ignacio Chávez – INCICh México City, México
      • Kuang-Tien General Hospital (Taichug, Taiwan)
      • University Hospital “Policlinico Umberto I”
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Arrhythmia Management Devices

Implantable Cardioverter-Defibrillator Leads

Design, Diagnostics, and Management

Charles D. Swerdlow, Kenneth A. Ellenbogen
Download PDF
https://doi.org/10.1161/CIRCULATIONAHA.113.003920
Circulation. 2013;128:2062-2071
Originally published October 28, 2013
Charles D. Swerdlow
From Cedars-Sinai Heart Institute and David Geffen School of Medicine at UCLA, Los Angeles, CA (C.D.S.), and Virginia Commonwealth University School of Medicine, Richmond, VA (K.A.E.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Ellenbogen
From Cedars-Sinai Heart Institute and David Geffen School of Medicine at UCLA, Los Angeles, CA (C.D.S.), and Virginia Commonwealth University School of Medicine, Richmond, VA (K.A.E.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Introduction
    • Design and Failure Modes: Engineering–Clinical Correlations
    • Preclinical Testing and Postmarket Surveillance of Defibrillation Leads
    • Incidence and Mechanisms of Lead Failure
    • Lead Failure: Clinical Presentation and Diagnostic Tools
    • Impedance and Impedance Trends
    • Shock Impedance in Failures of High-Voltage Lead Components
    • Diagnostics for Pace-Sense Lead Integrity
    • Differential Diagnosis of Pace-Sense Failures
    • Approach to the Patient
    • Managing At-Risk Leads
    • Future Directions and Summary
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading
  • equipment failure
  • implantable cardioverter-defibrillators

Introduction

The transvenous defibrillation lead was a critical technological step that enabled widespread adoption of implantable cardioverter-defibrillator (ICD) therapy. This lead is the most vulnerable component of the ICD system. It must remain chemically inert in a hostile biological environment, withstand flexing for hundreds of millions of cardiac cycles, and retain electrical integrity during shocks that would trip a household circuit breaker. Reliability issues concerning leads have led to the rethinking of lead design, reexamination of preclinical testing, implementation of algorithms that warn of lead failure and reduce inappropriate shocks, design of leads that can be extracted more easily, and development of a totally subcutaneous ICD system. The present review summarizes clinical aspects of defibrillation leads and reviews diagnostic and therapeutic approaches to lead failure.

Design and Failure Modes: Engineering–Clinical Correlations

Please see the online-only Data Supplement for a brief summary of the engineering of lead design.

Structural Overview

Right ventricular (RV) defibrillation leads comprise a distal tip electrode with a fixation mechanism that anchors the lead to the heart, proximal terminals that connect to the generator, and a lead body that connects the two (Figure 1A). The lead body consists of a flexible insulating cylinder with 3 to 6 parallel longitudinal lumens through which conductors run from the proximal terminals to small pace-sense electrodes and larger shock coil electrodes. This multilumen design (Figure 1B) permits more conductors in smaller-diameter leads than older coaxial designs.1 The subcutaneous ICD uses a parasternal electrode in which the larger shock coil is straddled by 2 small sensing electrodes (Figure 1C).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Structure of true bipolar leads in which the active fixation screw acts as the distal pace-sense electrode. A, Top, Dual-coil active fixation lead with DF-1/IS-1 terminal pins. Bottom, Single-coil active fixation lead with DF-4 terminal pins. B, Cross section of multilumen, dual-coil, true bipolar lead (Durata, St. Jude Medical, St Paul, MN) with silicone rubber body through which 3 pairs of cables run to the 2 shock coils and ring electrode. Helix to tip electrode with fixation mechanism is at center. C, Subcutaneous implantable cardioverter-defibrillator electrode with shock coil straddled by 2 sensing electrodes (SE). D, Distal end of leads highlights sensing electrodes. Top, True bipolar lead (Durata, St. Jude Medical). Bottom, Integrated bipolar lead (Endotak Reliance G, Boston Scientific, Natick, MA). ETFE indicates ethylene-tetrafluoroethylene; PTFE, polytetrafluoroethylene; RV, right ventricular; and SVC, superior vena cava.

Clinical Significance of Functional Elements in Transvenous Defibrillation Leads

ICD leads differ in number of shock coils, number of sensing electrodes, and type of connector terminals.

Dual-Coil Versus Single-Coil Leads

All transvenous leads have a distal shock coil in the RV. Dual-coil leads have an additional proximal shock coil, which usually lies in the superior vena cava (Figure 1A). Dual-coil leads were required for the first transvenous ICD systems, which preceded those in which the housing (can) of the generator served as a defibrillation electrode (active can). With contemporary biphasic waveforms and active cans, differences in defibrillation efficacy between dual-coil and single-coil shock pathways are rarely clinically significant for left-pectoral implants.

The principal disadvantage of dual-coil leads is greater risk of extraction because of fibrotic tissue ingrowth into the proximal coil.2 An additional disadvantage is the possibility of a short between high-voltage elements of opposite polarity. However, dual-coil leads retain advantages, including more reliable atrial cardioversion,3 coil-coil electrograms for morphology algorithms that discriminate ventricular from supraventricular tachycardia, and proximal coil-can electrograms that display atrial signals to improve interpretation of single-chamber electrograms.

Integrated Versus True Bipolar Sensing

Sensing can either be true bipolar between the tip electrode and a small ring electrode or integrated bipolar between the tip electrode and RV coil (Figure 1D). Modern integrated bipolar and true bipolar leads have similar performance for sensing ventricular fibrillation (VF)4 but differ in susceptibility to oversensing.5,6 The larger integrated bipolar antenna is more susceptible to external electromagnetic interference, R-wave double counting, and diaphragmatic myopotentials. True bipolar leads are more susceptible to T-wave oversensing, probably because of greater variations in R-wave amplitude. There is no consensus regarding which is preferred.

Connector Terminals

Until recently, ICD lead terminals comprised an IS-1 pin for the pace-sense bipole and a DF-1 pin for each high-voltage coil (Figure 1A, upper panel). The new DF-4 design (Figure 1A, lower panel) has a single 4-pole connector that connects to a smaller header. This reduces bulk in the pocket, obviates stress at the trifurcation/bifurcation point, and prevents accidental reversal of high-voltage connections; however, it requires an adapter to add a shock coil if defibrillation is unreliable.

Preclinical Testing and Postmarket Surveillance of Defibrillation Leads

Preclinical Testing

In collaboration with manufacturers and government, the International Organization for Standardization (ISO) has established 5 standards for preclinical bench testing relating to mechanical performance, electrical performance, biostability, biocompatibility, and interchangeability (ISO 5841-3, 14708-1, 14708-6, 11318, and 27186). These standards are based on properties of older lead designs thought to have acceptable performance, without consideration of how changes in design or materials affect failure modes. They have not prevented market release of leads with unacceptable performance, which has resulted in substantial morbidity and psychosocial costs for many patients and an enormous economic burden for taxpayers. The Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines7 is largely silent on preclinical testing. Presently, manufacturers, government, and industry are collaborating to develop improved standards through the Association for the Advancement of Medical Instrumentation Cardiac Rhythm Management Committee Working Group on Leads.

Manufacturers also perform proprietary preclinical tests, informed by studies of biomechanics and the performance of predicate leads and often assisted by computer modeling. Some tests are accelerated by increasing the temperature to alter kinetics of chemical reactions or by increasing the frequency or magnitude of mechanical stresses. However, there are few validated metrics for predicting lead performance on the basis of accelerated testing.

Postmarket Surveillance

Preclinical testing and short-term clinical trials in small populations cannot identify all failure modes during the service life of ICD leads.7 Three methods of postmarket surveillance are used to protect patients from failure modes that occur only during long-term implantations. The first is analysis of returned products and complaints. This method is critical to determine the root cause of failures and facilitate improved lead designs; however, passive surveillance that depends on physician reporting cannot determine the status of leads that have not been reported to the manufacturer. Estimation of lead survival based on passive methods requires assumptions about the status of unreported leads and thus introduces potential errors. The second method comprises long-term prospective audits that actively monitor the status of each lead in research studies or registries. Such active methods permit better estimates of lead performance if investigators collect and report data meticulously; however, even active methods may not identify important lead failures that result in patient death. Furthermore, because cost limits the sample size of active methods, they may not estimate the rate of rare failure modes accurately. These methods are supplemented by a third, analyses of Internet-based remote-monitoring networks. This enables surveillance of large populations of leads and usually permits determination that a lead has been replaced but is less accurate than active methods and provides less detail. Because the method of data collection influences reported performance, lead performance should not be compared between studies that use different methods.

Incidence and Mechanisms of Lead Failure

The incidence of defibrillation lead failure has been studied in large single-center and multicenter registries.8,9 In one study, the overall incidence of clinical lead failure was 1.3 per 100 lead-years, excluding leads with known high failure rates.8 There are 2 primary structural mechanisms of lead failure: Conductor fracture, best studied in recalled Sprint Fidelis (Fidelis) leads from Medtronic (Minneapolis, MN), and insulation breach, best studied in the recalled Riata family of leads from St. Jude Medical (St Paul, MN).

Fidelis Conductor Fractures

Fidelis is a highly flexible lead that permits bending with a short radius, which increases the force applied to the coil and cable. Analysis of malfunctioning Fidelis leads found that pace-sense conductors failed in 94%.10 Of these, 43% involved the central helical coil to the tip electrode and 57% involved the cable to the ring electrode.11 All coil fractures occurred at the anchor sleeve (Figure 2A), a region of low-cycle, high stress associated with shoulder motion. Sharp angulation at axillary vein insertion sites may increase the risk of failure. In contrast, most cable fractures occurred proximal to the ring electrode, where the lead undergoes high-cycle, weak stress with each cardiac cycle. To make the distal lead less flexible, silicone backfill was injected into the cable lumen at this location. Fractures occur at this transition from the more flexible lead body to the less flexible distal segment. The root cause is restricted motion of the cable in its narrow lumen, which prevents it from sliding with each cardiac cycle so that this transition serves as a hinge point for the cable.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

A, Conductor fracture at tie-down sleeve (Medtronic Sprint Fidelis). Upper left, Radiograph shows sharp angulation (arrow) of lead at axillary vein insertion site, often associated with fracture of pace-sense coil to helix. Upper right, Photograph during bench testing reproduces fracture (arrow) with sharp angulation just distal to sleeve (S). Lower left, Industrial-quality radiograph shows fracture. Lower right, Scanning electron micrograph shows fractured helix coil in radiograph to right. B, Inside-out silicone insulation breach (St. Jude Medical leads). Top, Riata lead with exteriorized cables; cinefluoroscopy frame (left; white arrows denote exteriorized cables) and corresponding photograph (right) of explanted lead. Bottom, Durata lead with outer copolymer tubing removed in central section. Blue ethylene-tetrafluoroethylene insulation is visible on cable to ring electrode, which has abraded inside-out through the lumen of its tubing. Additional cables at top and bottom remain within their lumens.

High-voltage fractures occur in 14% of failed Fidelis leads, 6% in isolation and 8% with pace-sense fractures.10 In 25 leads, 56% of high-voltage fractures occurred in the cable to the distal coil, 36% in the cable to the proximal coil, and 8% in both.6

Riata-Family Insulation Breaches

Outside-in in-pocket, lead-can, or lead-lead abrasions may occur with any lead, but silicone leads without an outer protective coating are at highest risk. Abrasion of pace-sense components against the can results in oversensing of pectoral myopotentials, whereas abrasion of the cable to the distal coil shorts the high-voltage output, which prevents shocks from reaching the heart. Despite protection circuitry that aborts shocks into shorted outputs, excessive current in the output circuits may cause catastrophic generator failure.12,13

St. Jude multilumen silicone-body leads include the 8F Riata and downsized 7F Riata ST, which lack an outer protective coating. The 7F Riata ST Optim and Durata models have an outer copolymer coating to prevent coil-can abrasions. (See Appendix in the online-only Data Supplement; Durata also has a redesigned tip to minimize risk of cardiac perforation at implantation.) All of these leads have large-diameter lumens that permit the cables to move more freely than narrower lumens. Internal motion of cables is the root cause of a unique failure mode in which the cables abrade against and through the silicone elastomer insulation that constitutes the walls of their lumens,14,15 which results in inside-out insulation breaches (Figure 2B).14 Approximately 80% of these breaches occur between the shock coils, and 10% occur under the coils.14

In leads without external copolymer tubing, abrasions between the coils present most commonly as exteriorized cables14 that are identified radiographically. At diagnosis, routine follow-up identifies >70% of leads as having normal electrical function16 because of the biocompatibility and high dielectric strength of intact ethylene-tetrafluoroethylene (ETFE) insulation (Figure 1; Appendix in the online-only Data Supplement). Some engineering considerations predict that inside-out abrasions should occur less frequently in 7F leads than 8F leads because the conductor lumens are narrower and closer to the central axis.17 This is supported by a prospective study in which exteriorized cables were more common in 8F leads than 7F leads (17.9% versus 9.4% for leads implanted <6 years). However, variation in reported rates may be caused by lack of standardized imaging and uniform definitions. External copolymer tubing prevents cable exteriorization but not the root cause, inside-out abrasions.

Inside-out abrasions that do not cause exteriorized cables are significant clinically when they cause interactions between conductors. Of these, the most important occur under the shock coils and are not identified radiographically. Contact between the proximal coil and cable to the distal coil shorts the high-voltage conductors, which prevents successful defibrillation.18–20 Contact of the ring electrode cable with either shock coil results in sensing abnormalities.20,21

Lead Failure: Clinical Presentation and Diagnostic Tools

Clinical Presentations

Pace-sense malfunctions account for the majority of clinically diagnosed lead failures.9 The most common presentation of either conductor fracture or insulation breach is oversensing of rapid nonphysiological signals.11,22 Before diagnostic tools that incorporated oversensing, pace-sense fractures presented most commonly as inappropriate shocks, despite daily automated measurements of pacing impedance.23,24 Oversensing also results in inhibition of pacing. Pace-sense malfunctions may also present with loss of capture. Functional pace-sense failure at the electrode-myocardial interface may result in undersensing of low-amplitude electrograms or elevated pacing threshold.

Because there are fewer diagnostic tools for shock components than pace-sense components, the true incidence of shock-component failures may be higher than identified. Clinically, patients may present with failed defibrillation. Insulation breaches that short high-voltage outputs may cause catastrophic failure of the pulse generator. Presently, however, lead failure is often detected before clinical consequences occur because of diagnostic tools that include electrograms, impedance measurements, and lead-failure algorithms.

Electrograms in Lead Failure

Because oversensing is the primary presentation of pace-sense lead failure, electrograms and their annotated event markers (commonly referred to by the trademarked term Marker Channel [Medtronic]) play a central diagnostic role. Events that occur on the sensing channel but not the shock channel indicate oversensing. Stored electrograms are the primary source data for oversensing that results in inappropriate detection of nonsustained or sustained VF. Real-time electrograms are useful in troubleshooting by demonstrating reproducible oversensing. These include lead or connector problems in the pocket that may be identified by pocket manipulation or arm exercise and pectoral or diaphragmatic myopotentials, which do not necessarily indicate lead failure and can be provoked by pectoral muscle exercise and straining, respectively.

Pace-Sense Conductor Fracture

Typical nonphysiological fracture electrograms validated by analysis of explanted leads have 5 subjective characteristics (Figure 3)25: They always have (1) high frequency and (2) occur intermittently. In true bipolar leads, (3) they are not recorded on the shock channel. Typically, (4) they are highly variable in amplitude and frequency (noisy) and usually have a component that is unrelated to the cardiac cycle. Often, (5) they saturate the sensing amplifier. In our experience, the simultaneous occurrence of the first 4 characteristics is specific for lead-system issues (fracture or connector problem), and the combination of all 5 is diagnostic. We refer to the first 4 findings with or without saturation as lead-system noise; however, lead-system noise is only moderately sensitive. In one study, 28% of fractures presented with no or only minor oversensing.26 Nonphysiological signals are often atypical, including only low-amplitude signals and signals that vary with the cardiac cycle, which indicates an intracardiac source (Figure I in the online-only Data Supplement). Fracture-related signals may be precipitated by pacing, especially high-output pacing (Figure I in the online-only Data Supplement).27

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Sensing and shock electrograms (EGM) with marker channel illustrate characteristics of typical nonphysiological noise from conductor fracture. Shock above 35.1 J annotation on marker channel indicates delivery of shock for inappropriate detection of ventricular fibrillation (VF Rx 1 Defib) on marker channel. See text for details. VS, TS, and FS indicate intervals in sinus, ventricular tachycardia, and ventricular fibrillation zones, respectively; FD indicates detection of ventricular fibrillation.

The mechanism of fracture-related signals is not established. They are often referred to as make-break potentials because similar signals can be generated by connecting and disconnecting cables from the sensing circuit28 and because it is surmised that a similar process generates signals during intermittent contact between fractured sections of the helix or broken filaments of a cable (Figure 2A). However, make-break potentials do not explain how pacing can induce fracture-related signals.

Insulation Breach

Data are limited regarding characteristics of pace-sense electrograms in leads with insulation breaches. Unlike conductor fractures, insulation breaches themselves do not generate abnormal signals. Instead, they result from secondary effects on conductors. These include physiological signals conducted through the insulation breach and nonphysiological signals that arise from interactions of different conductors within the lead body. Intermittent high-amplitude pectoral myopotentials on the sensing channel suggest in-pocket, outside-in abrasion (Figure 4A)29; however, continuous pectoral myopotentials may be recorded on shock electrograms and do not indicate lead failure. Electrograms associated with clinically diagnosed failures of Riata leads often showed characteristic spikes on both sensing and shock channels that may represent interactions between conductors in the lead (Figure 4B).29 Simultaneous nonphysiological signals on the shock and sensing electrograms have been reported in inside-out abrasion of the ring electrode cable against the RV shock coil (Figure 4C).21 When cyclical, they may be confused with physiological T waves.21

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Electrograms of insulation breaches. A, Outside-in coil-can abrasion breaches outer silicone and inner ethylene-tetrafluoroethylene insulation, exposing the ring electrode cable (arrow). True bipolar sensing electrogram recorded between ring and tip electrodes in right ventricular (RV) apex shows high-frequency signals, probably caused by pectoral myopotentials. B, Simultaneous spikes on sensing and shock channels suggest interaction between conductors. C, Simultaneous cyclical signals on the shock and sensing electrograms caused by inside-out abrasion of the ring electrode cable against the RV shock coil. Magnified image at right shows abraded silicone and ethylene-tetrafluoroethylene, exposing metal ring electrode cable at proximal end of RV shock coil. From Swerdlow et al.21 Authorization for this adaptation has been obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.

Impedance and Impedance Trends

Pace-Sense Circuits

Electrical integrity is evaluated by periodic measurement of the entire circuit’s direct-current electrical resistance (R), commonly referred to as impedance monitoring, by measuring voltage (V) and current (I) and applying Ohm’s law (R=V/I). The circuit comprises the connection between the generator’s header and the lead, the conductors to the tip and ring electrodes, and the electrode-myocardial interface. The pace-sense conductors and electrodes account for only 30 to 50 Ω of the typical circuit’s 300- to 1000-Ω impedance. Because most of the resistance is at the interface between tissue and the tip electrode, impedance is insensitive. A few fractured cable filaments may generate nonphysiological signals without measurable alteration in circuit impedance. Out-of-range values occurred before oversensing in only 28% of confirmed Fidelis fractures26 and 15% of clinically diagnosed Riata failures.22

Abrupt relative changes in impedance are more specific than absolute measurements, which record out-of-range values for gradual changes at the electrode-myocardial interface,25 but a single abrupt change can be spurious. Pacing impedance <200 Ω is thought to indicate an insulation breach, but evidence is limited (Figure 5).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Impedance trends for pace-sense electrodes. To the left of the longest vertical line, data are displayed as vertical bars connecting weekly maximum and minimum impedance values. To the right, black points indicate daily values. A, Normal impedance trend. Although this trend occurred in a normal lead, normal trends may occur in conductor fractures and insulation failures. B, Lead insulation failure shows a late abrupt fall in impedance. C, Connection problem between header and lead caused by incomplete pin insertion shows highly variable impedances beginning ≈4 months after implantation, followed by an ≈2-month return to baseline between early October and December 2007. D, Lead conductor fracture with late abrupt increase in impedance to highest reported value (>3000 Ω). E, Engineering-level display of stored data for another lead conductor fracture. Although programmer only displays impedance up to a maximum value of 3000 Ω, impedance is measured up to 16 000 Ω. Late abrupt impedance increase to open-circuit value is diagnostic of conductor fracture. F, Gradual increase in impedance in normally functioning lead, thought to be caused by changes at electrode-myocardial interface. From Swerdlow et al.30 Authorization for this adaptation has been obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.

Shock Circuits

The circuit comprises the connection between header and lead, high-voltage conductor cables, shock electrodes, blood in the right atrium and RV, and (provided that the can is included) heart, lung, and chest wall. High-voltage cables and shock electrodes have low impedance (1–2 Ω). The overall circuit typically has resistance in the range of 30 to 50 Ω for single-coil leads and 50 to 80 Ω for dual-coil leads. Two factors complicate low-voltage, painless impedance measurement. First, because tissue resistance is inversely related to voltage, painless measurements must be corrected to approximate high-voltage measurements. Second, respiratory variation is greater at low voltages.

Shock Impedance in Failures of High-Voltage Lead Components

Impedance measurements remain the primary diagnostic tool for high-voltage conductors.

High-Voltage Conductor Fractures

High-voltage conductor fractures present either as asymptomatic abrupt increases in impedance or as unsuccessful shocks. Limited data indicate that an impedance threshold >100 Ω or an abrupt 75% increase in chronic impedance identifies Fidelis fractures.6 Abnormally high shock impedance may also be caused by high-voltage connection issues or improper calibration of low-voltage measurements.

High-Voltage Insulation Breaches

Low impedance has been reported, but thresholds have not been validated. Furthermore, diagnosis of partial insulation breaches remains a critical challenge: Low-voltage test pulses below the dielectric-breakdown voltage encounter intact insulation, but high-voltage shocks above that voltage may cause catastrophic short circuits in either outside-in in-pocket coil-can abrasions12,13 or inside-out abrasions of the cable to the distal-coil under the proximal coil.17,19 Abnormally low impedance may also be caused by reversed connection of proximal and distal shock coils to the header on IS-1 leads.

Diagnostics for Pace-Sense Lead Integrity

Monitoring of both rapid oversensing and impedance improves early detection of lead failure compared with monitoring of impedance alone.11,26,31

Sensing Integrity Count

Extremely short R-R intervals near the ventricular blanking period do not represent successive cardiac depolarizations except occasionally during VF. Medtronic ICDs count sensed ventricular intervals ≤130 ms as a measure of nonphysiological oversensing and store it as the sensing integrity count. A rapidly increasing sensing integrity count (>10 per day for 3 consecutive days) is a sensitive indicator of pace-sense lead fracture, but in isolation it has low specificity (≈20%).11 The most common causes of isolated extremely short intervals are nonphysiological combinations of physiological signals (eg, T-wave oversensing followed by a premature ventricular beat).32

Lead Integrity Alert

The lead integrity alert algorithm includes 1 criterion related to abnormal pace-sense impedance and 2 related to transient rapid oversensing (Figure II in the online-only Data Supplement). If any 2 criteria are fulfilled, it immediately triggers an audible alert tone, which repeats every 4 hours. If enabled, it triggers an Internet-based alert. The false-positive rate is low, and lower for true bipolar than for integrated bipolar leads because of triggering by electromagnetic interference in integrated bipolar leads (<1/400 versus 1/80 patient-years).11,26,32 Once an alert is triggered, the lead integrity alert sounds an audible tone, initiates an immediate remote-monitoring notification in ICDs with wireless telemetry, and reprograms the number of intervals to detect VF to 30/40, which reduces inappropriate shocks caused by transient, fracture-induced oversensing.11 In a prospective study, the lead integrity alert reduced inappropriate shocks compared with conventional impedance monitoring (lead integrity alert 38% versus control 70%, P<0.001).

Algorithms That Compare Sensing and Shock Electrograms

Two algorithms (Medtronic lead noise algorithm and St. Jude SecureSense) identify oversensed, nonphysiological pace-sense signals as those that do not correlate temporally with electrograms on the shock channel. Both withhold shocks if sufficient oversensing occurs (Figure III in the online-only Data Supplement). In preclinical testing, the lead noise algorithm did not prevent or delay therapy for true VF.28 Clinical performance has not been published for either algorithm; however, both may be triggered by oversensing unrelated to lead failure. A limitation of these algorithms is that they do not identify nonphysiological signals that occur simultaneously on sensing and shock channels, such as those caused by cable-coil abrasions21 (Figure 4C).

Remote Monitoring

Remote Internet-based monitoring facilitates diagnosis of lead failure. ICDs with wireless telemetry automatically transmit stored data, including lead alerts. Wireless remote monitoring shortens the time from the alert to decision making or intervention.33 The combination of wireless remote monitoring and a lead integrity alert reduces inappropriate shocks.33

Radiography and Other Imaging

Imaging plays a limited role in diagnosing lead failure. The chest radiograph is important primarily for the exclusion of alternative diagnoses such as dislodgement with or without perforation and incomplete insertion of connector pins into the header25 (Figure IV in the online-only Data Supplement). The latter may require spot films or intraoperative radiographs. On the radiograph, the lead should be inspected for conductor discontinuity, kinks or sharp bends (especially at lateral axillary venous insertions; Figure 2A), and evidence of twiddler’s syndrome. Riata leads should be inspected for exteriorized cables. Usually, however, the radiograph in lead failure is unrevealing.

Cinefluoroscopy is the primary method of identifying Riata exteriorized cables. These present characteristic images in which the inner cables protrude outside the outer insulation (Figure 2C). They are identified if either the separation between conductors is larger than the diameter of the shock coil or the radius of curvature of a suspected externalized conductor is significantly different from that of the rest of the lead body.17

Differential Diagnosis of Pace-Sense Failures

Accurate diagnosis is important because other conditions can cause both abnormal impedance and oversensing,25 and overdiagnosis results in unnecessary lead replacements. Table 1 summarizes the differential diagnosis.

View this table:
  • View inline
  • View popup
Table 1.

Differential Diagnosis of Pace-Sense Lead Failure

Abnormal Pacing Impedance With or Without Oversensing

Gradual impedance rises without oversensing occur in normally functioning leads because of changes at the electrode-myocardial interface25; however, high impedance combined with oversensing indicates a fracture or connection problem. Electrogram characteristics of lead-system noise do not differentiate fractures from connection problems (Figure V in the online-only Data Supplement),25 but impedance trends can discriminate them (Figure 5).25

Connection problems include loose setscrews, weakened ICD header bonds, adapter problems, and incomplete contact between the lead pin and header34; they constitute up to 10% suspected fractures.11,25 Abrupt impedance rise within 30 days after a new lead implantation is a connection problem, provided that lead dislodgement is excluded. However, incomplete pin insertion may cause late impedance rises; 46% of cases presented >6 months after the last surgical procedure.25 A long period in which impedance returns to baseline after an abrupt rise indicates a connection problem. Radiography reliably diagnoses incomplete contact between the lead pin and header. If operative intervention is required, the ICD should be inspected for incomplete insertion of the lead pin into the header, loose setscrews, and other header problems before the lead is disconnected. Table 2 summarizes characteristics of connection problems caused by incomplete pin insertion.

View this table:
  • View inline
  • View popup
Table 2.

Clues to Diagnosis of Header-Connection Problems Caused by Incomplete Pin Insertion

Reduced pacing impedance has been reported with insulation breaches in older coaxial defibrillation leads35 and rarely in silicone abrasions of multilumen leads,22 but most breaches in multilumen leads present with impedance within the nominal range, although some have reduced impedance within that range. Optimal diagnostic criteria are unknown.

Rapid Oversensing With Normal Pacing Impedance

Because connection problems always present with high impedance after the perioperative period, lead-system noise with a normal impedance strongly favors lead failure if it presents >30 days postoperatively.25 However, conditions other than ICD system issues can cause repetitive, extremely short sensed R-R intervals with normal impedance, and their electrograms must be distinguished from lead-system noise. Uniform, rapid, medium-frequency signals shortly after implantation or generator change are caused by air trapped in the header that escapes through a seal plug. Lead-lead mechanical interactions32 can be suspected on the basis of history or radiography. In extremely rapid true VF,32 the shock electrogram confirms the diagnosis. High-frequency diaphragmatic myopotentials occur most commonly with integrated bipolar leads placed at the RV apex.25 They are distinguished by uniformly low amplitude and relatively uniform morphology (Figure VA in the online-only Data Supplement).

Approach to the Patient

Suspected Pace-Sense Component Failure

Detection of VF should be disabled immediately in any patient with lead-system noise that is the cause of inappropriate shocks. Diagnosing a single out-of-range impedance measurement without other signs of lead malfunction is less urgent and may require observation. In true bipolar leads, connection problems caused by incomplete pin insertion may be corrected by programming integrated bipolar sensing (if this option is available), but long-term outcomes of this programming strategy have not been reported. Integrated bipolar sensing also resolves oversensing related to failure of the ring electrode conductor. This is not recommended as a long-term solution in Fidelis leads, because other lead elements have a higher risk of failure.10 For normally functioning leads with a gradual impedance rise to <2500 Ω, limited data support follow-up without operative intervention.25 If the impedance rise is abrupt, incomplete pin insertion should be excluded by radiography or intraoperative inspection before lead replacement. Insulation breaches typically require lead replacement.

Suspected High-Voltage Component Failure

Abnormally high low-voltage measurement of shock impedance should be confirmed by a high-voltage shock to exclude erroneous measurements. There is no consensus on whether isolated fractures of the proximal coil require lead replacement or only that the proximal coil be programmed out of the shock circuit and that defibrillation be retested. Abnormally low shock impedance requires prompt lead replacement for insulation breach, provided that reversed shock coil connections are excluded. If the ICD generator is to be reused, a high-voltage shock should not be delivered because of the risk of damaging the output circuit.

Managing At-Risk Leads

At Recall

The whole story is rarely clear. Usually, understanding of failure rates and optimal management strategies is incomplete. We are quick to optimize patient-specific programming, to confirm appropriate remote monitoring, and to notify patients empathetically, but slow to replace normally functioning leads, and careful to reassess over time. Physicians must provide explanations that patients can understand,36 and physicians must understand that risk is perceived differently when it is personal. Management requires both a patient-specific and patient-centered approach. The online-only Data Supplement Appendix provides specific considerations for Fidelis and Riata leads.

At Generator Replacement

Generator replacement provides the opportunity to replace normally functioning at-risk leads and the generator at a single procedure, potentially avoiding infection risks of a subsequent procedure to replace a failed lead. The best approach depends on accurate knowledge of procedural risk, failure rate, and consequences of lead failure. If mortality is the only consideration, generator replacement alone is usually preferred to lead replacement for Fidelis leads, except possibly in pacemaker-dependent patients.37 In practice, the preferred strategy depends on trade-offs among mortality, procedural complications, cost, quality of life as measured by inappropriate shocks, and patient anxiety. If lead replacement is selected, options include insertion of a new lead only or extraction and replacement. The decision depends on the risk of extraction, which in turn depends on the patient, operator/institution, and specific lead model.2 Table 3 summarizes factors relevant to this decision.

View this table:
  • View inline
  • View popup
Table 3.

Risk–Benefit Considerations for Managing Normally Functioning At-Risk Leads

Future Directions and Summary

Present research includes development of antibacterial coating to reduce infections, polymer coatings to facilitate extraction, and design changes to make leads conditionally safe for magnetic resonance imaging. However, development of biostable and durable transvenous defibrillation leads remains both a materials science and mechanical engineering challenge. Until that challenge is overcome, clinicians must be able to recognize presentations of lead failure and understand the trade-offs among management options. Data from registries of patients are especially important, because failure rates may vary over time, and systematic failures may not be identified until years after implantation. Cooperation and open communication among physicians, industry, and the US Food and Drug Administration will facilitate rapid dissemination of evidence-based strategies to achieve the best outcomes for our patients.

Disclosures

Dr Swerdlow has served as a consultant or received honoraria from Medtronic, St. Jude Medical, and Sorin and has received research grants from Medtronic. Dr Ellenbogen has served as a consultant or received honoraria from Biotronik, Biosense Webster, Boston Scientific, Medtronic, and St. Jude Medical; served on the speakers’ bureau for Biotronik, Boston Scientific, and Medtronic; received research grants from Boston Scientific, Medtronic, and St. Jude Medical; and has received fellowship support from Medtronic, Boston Scientific, and Biosense Webster.

Footnotes

  • Guest Editor for this article was John Triedman.

  • The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.113.003920/-/DC1.

  • © 2013 American Heart Association, Inc.

References

  1. 1.↵
    1. Haqqani HM,
    2. Mond HG
    . The implantable cardioverter-defibrillator lead: principles, progress, and promises. Pacing Clin Electrophysiol. 2009;32:1336–1353.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Epstein LM,
    2. Love CJ,
    3. Wilkoff BL,
    4. Chung MK,
    5. Hackler JW,
    6. Bongiorni MG,
    7. Segreti L,
    8. Carrillo RG,
    9. Baltodano P,
    10. Fischer A,
    11. Kennergren C,
    12. Viklund R,
    13. Mittal S,
    14. Arshad A,
    15. Ellenbogen KA,
    16. John RM,
    17. Maytin M
    . Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. J Am Coll Cardiol. 2013;61:987–989.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Rashba EJ,
    2. Shorofsky SR,
    3. Brown T,
    4. Peters RW,
    5. Gold MR
    . Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm. 2005;2:49–54.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Verga TA,
    2. Gillberg JM,
    3. Greenberg RM,
    4. Deger FT
    . True bipolar and integrated bipolar sensing and detection by implantable defibrillators. Pacing Clin Electrophysiol. 2011;34:1561–1568.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Powell BD,
    2. Asirvatham SJ,
    3. Perschbacher DL,
    4. Jones PW,
    5. Cha YM,
    6. Cesario DA,
    7. Cao M,
    8. Gilliam FR 3rd.,
    9. Saxon LA
    . Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study. Pacing Clin Electrophysiol. 2012;35:863–869.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Koneru JN,
    2. Gunderson BD,
    3. Sachanandani H,
    4. Wohl BN,
    5. Kendall KT,
    6. Swerdlow CD,
    7. Ellenbogen KA
    . Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads. Heart Rhythm. 2013;10:813–818.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Maisel WH,
    2. Hauser RG,
    3. Hammill SC,
    4. Hauser RG,
    5. Ellenbogen KA,
    6. Epstein AE,
    7. Hayes DL,
    8. Alpert JS,
    9. Berger RD,
    10. Curtis AB,
    11. Dubin AM,
    12. Estes NA 3rd.,
    13. Gura MT,
    14. Krahn AD,
    15. Lampert R,
    16. Lindsay BD,
    17. Wilkoff BL
    ; Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines; American College of Cardiology (ACC); American Heart Association (AHA). Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6:869–885.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Borleffs CJ,
    2. van Erven L,
    3. van Bommel RJ,
    4. van der Velde ET,
    5. van der Wall EE,
    6. Bax JJ,
    7. Rosendaal FR,
    8. Schalij MJ
    . Risk of failure of transvenous implantable cardioverter-defibrillator leads. Circ Arrhythm Electrophysiol. 2009;2:411–416.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Kleemann T,
    2. Becker T,
    3. Doenges K,
    4. Vater M,
    5. Senges J,
    6. Schneider S,
    7. Saggau W,
    8. Weisse U,
    9. Seidl K
    . Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474–2480.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Medtronic Inc. Sprint Fidelis® Lead Patient Management Recommendations Update: Models 6949, 6948, 6931, 6930. Medtronic Web site. April2011. http://www.medtronic.com/wcm/groups/mdtcom_sg/@mdt/documents/documents/fidelis-phys-ltr-2011-04.pdf. Accessed April 21, 2013.
  11. 11.↵
    1. Swerdlow CD,
    2. Gunderson BD,
    3. Ousdigian KT,
    4. Abeyratne A,
    5. Stadler RW,
    6. Gillberg JM,
    7. Patel AS,
    8. Ellenbogen KA
    . Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation. 2008;118:2122–2129.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Leong DP,
    2. van Erven L
    . Unrecognized failure of a narrow caliber defibrillation lead: the role of defibrillation threshold testing in identifying an unprotected individual. Pacing Clin Electrophysiol. 2012;35:e154–e155.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Catanzaro JN,
    2. Brinker JA,
    3. Sinha SK,
    4. Cheng A
    . Abrasion of a DF-4 defibrillator lead. J Cardiovasc Electrophysiol. 2013;24:719.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Hauser RG,
    2. McGriff D,
    3. Retel LK
    . Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect. Heart Rhythm. 2012;9:742–749.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Kallinen LM,
    2. Hauser RG,
    3. Tang C,
    4. Melby DP,
    5. Almquist AK,
    6. Katsiyiannis WT,
    7. Gornick CC
    . Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures. Heart Rhythm. 2010;7:1048–1055.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Theuns DA,
    2. Elvan A,
    3. de Voogt W,
    4. de Cock CC,
    5. van Erven L,
    6. Meine M
    . Prevalence and presentation of externalized conductors and electrical abnormalities in Riata defibrillator leads after fluoroscopic screening: report from the Netherlands Heart Rhythm Association Device Advisory Committee. Circ Arrhythm Electrophysiol. 2012;5:1059–1063.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Abdelhadi RH,
    2. Saba SF,
    3. Ellis CR,
    4. Mason PK,
    5. Kramer DB,
    6. Friedman PA,
    7. Gura MT,
    8. DiMarco JP,
    9. Mugglin AS,
    10. Reynolds MR,
    11. Bazaz RR,
    12. Retel LK,
    13. Hayes DL,
    14. Hauser RG
    . Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm. 2013;10:361–365.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Hauser RG,
    2. Abdelhadi RH,
    3. McGriff DM,
    4. Kallinen Retel L
    . Failure of a novel silicone-polyurethane copolymer (Optim™) to prevent implantable cardioverter-defibrillator lead insulation abrasions. Europace. 2013;15:278–283.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Shah P,
    2. Singh G,
    3. Chandra S,
    4. Schuger CD
    . Failure to deliver therapy by a Riata lead with internal wire externalization and normal electrical parameters during routine interrogation. J Cardiovasc Electrophysiol. 2013;24:94–96.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Goldstein MA,
    2. Badri M,
    3. Kocovic D,
    4. Kowey PR
    . Electrical failure of an ICD lead due to a presumed insulation defect only diagnosed by a maximum output shock. Pacing Clin Electrophysiol. 2013;36:1068–1071.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Swerdlow CD,
    2. Kass RM,
    3. Khoynezhad A,
    4. Tang S
    . Inside-out insulation failure of a defibrillator lead with abrasion-resistant coating. Heart Rhythm. 2013;10:1063–1066.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Sung RK,
    2. Massie BM,
    3. Varosy PD,
    4. Moore H,
    5. Rumsfeld J,
    6. Lee BK,
    7. Keung E
    . Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm. 2012;9:1954–1961.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Hauser RG,
    2. Kallinen LM,
    3. Almquist AK,
    4. Gornick CC,
    5. Katsiyiannis WT
    . Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007;4:892–896.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Krahn AD,
    2. Champagne J,
    3. Healey JS,
    4. Cameron D,
    5. Simpson CS,
    6. Thibault B,
    7. Mangat I,
    8. Tung S,
    9. Sterns L,
    10. Birnie DH,
    11. Exner DV,
    12. Parkash R,
    13. Sivakumaran S,
    14. Davies T,
    15. Coutu B,
    16. Crystal E,
    17. Wolfe K,
    18. Verma A,
    19. Stephenson EA,
    20. Sanatani S,
    21. Gow R,
    22. Connors S,
    23. Paredes FA,
    24. Essebag V
    ; Canadian Heart Rhythm Society Device Advisory Committee. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 2008;5:639–642.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Swerdlow CD,
    2. Sachanandani H,
    3. Gunderson BD,
    4. Ousdigian KT,
    5. Hjelle M,
    6. Ellenbogen KA
    . Preventing overdiagnosis of implantable cardioverter-defibrillator lead fractures using device diagnostics. J Am Coll Cardiol. 2011;57:2330–2339.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Swerdlow CD,
    2. Gunderson BD,
    3. Ousdigian KT,
    4. Abeyratne A,
    5. Sachanandani H,
    6. Ellenbogen KA
    . Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Circulation. 2010;122:1449–1455.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Chung EH,
    2. Casavant D,
    3. John RM
    . Analysis of pacing/defibrillator lead failure using device diagnostics and pacing maneuvers. Pacing Clin Electrophysiol. 2009;32:547–549.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Gunderson BD,
    2. Gillberg JM,
    3. Wood MA,
    4. Vijayaraman P,
    5. Shepard RK,
    6. Ellenbogen KA
    . Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2006;3:155–162.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Ellenbogen K,
    2. Gunderson B,
    3. Stromberg K,
    4. Swerdlow C
    . Performance of ICD Lead Integrity Alert to assist in the clinical diagnosis of ICD lead failures: analysis of different ICD leads. Circ Arrhythm Electrophysiol. In press.
  30. 30.↵
    1. Bonow R,
    2. Libby P,
    3. Mann D,
    4. Zipes D,
    5. Braunwald E
    1. Swerdlow C,
    2. Wang P,
    3. Zipes D
    . Cardiac pacemakers and implantable cardioverter-defibrillators In:Bonow R, Libby P, Mann D, Zipes D, Braunwald E, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, PA: Elsevier Saunders. In press.
  31. 31.↵
    1. Kallinen LM,
    2. Hauser RG,
    3. Lee KW,
    4. Almquist AK,
    5. Katsiyiannis WT,
    6. Tang CY,
    7. Melby DP,
    8. Gornick CC
    . Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2008;5:775–779.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Gunderson BD,
    2. Swerdlow CD,
    3. Wilcox JM,
    4. Hayman JE,
    5. Ousdigian KT,
    6. Ellenbogen KA
    . Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture. Heart Rhythm. 2010;7:626–633.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Blanck Z,
    2. Axtell K,
    3. Brodhagen K,
    4. O’Hearn L,
    5. Albelo T,
    6. Ceretto C,
    7. Dhala A,
    8. Sra J,
    9. Akhtar M
    . Inappropriate shocks in patients with Fidelis® lead fractures: impact of remote monitoring and the lead integrity algorithm. J Cardiovasc Electrophysiol. 2011;22:1107–1114.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Pickett RA 3rd.,
    2. Saavedra P,
    3. Ali MF,
    4. Darbar D,
    5. Rottman JN
    . Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection. J Cardiovasc Electrophysiol. 2004;15:1095–1099.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Gunderson BD,
    2. Patel AS,
    3. Bounds CA,
    4. Shepard RK,
    5. Wood MA,
    6. Ellenbogen KA
    . An algorithm to predict implantable cardioverter-defibrillator lead failure. J Am Coll Cardiol. 2004;44:1898–1902.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Mueller LA,
    2. Sharma A,
    3. Ottenberg AL,
    4. Mueller PS
    . Readability of “Dear Patient” device advisory notification letters created by a device manufacturer. Heart Rhythm. 2013;10:501–507.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Morrison TB,
    2. Friedman PA,
    3. Kallinen LM,
    4. Hodge DO,
    5. Crusan D,
    6. Kumar K,
    7. Hayes DL,
    8. Rea RF,
    9. Hauser RG
    . Impact of implanted recalled sprint Fidelis lead on patient mortality. J Am Coll Cardiol. 2011;58:278–283.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation
October 29, 2013, Volume 128, Issue 18
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Introduction
    • Design and Failure Modes: Engineering–Clinical Correlations
    • Preclinical Testing and Postmarket Surveillance of Defibrillation Leads
    • Incidence and Mechanisms of Lead Failure
    • Lead Failure: Clinical Presentation and Diagnostic Tools
    • Impedance and Impedance Trends
    • Shock Impedance in Failures of High-Voltage Lead Components
    • Diagnostics for Pace-Sense Lead Integrity
    • Differential Diagnosis of Pace-Sense Failures
    • Approach to the Patient
    • Managing At-Risk Leads
    • Future Directions and Summary
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Implantable Cardioverter-Defibrillator Leads
    Charles D. Swerdlow and Kenneth A. Ellenbogen
    Circulation. 2013;128:2062-2071, originally published October 28, 2013
    https://doi.org/10.1161/CIRCULATIONAHA.113.003920

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Implantable Cardioverter-Defibrillator Leads
    (Your Name) has sent you a message from Circulation
    (Your Name) thought you would like to see the Circulation web site.
  • Share on Social Media
    Implantable Cardioverter-Defibrillator Leads
    Charles D. Swerdlow and Kenneth A. Ellenbogen
    Circulation. 2013;128:2062-2071, originally published October 28, 2013
    https://doi.org/10.1161/CIRCULATIONAHA.113.003920
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Arrhythmia and Electrophysiology
    • Catheter Ablation and Implantable Cardioverter-Defibrillator

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured